Moderna Inc. (MRNA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Moderna Inc.

    NASDAQ: MRNA · Real-Time Price · USD
    24.83
    -0.31 (-1.23%)
    At close: Sep 08, 2025, 3:59 PM
    24.76
    -0.28%
    After-hours: Sep 08, 2025, 07:59 PM EDT

    Moderna Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -3.56B -4.71B 8.36B 12.2B
    Depreciation & Amortization
    		 189M 621M 348M 232M
    Stock-Based Compensation
    		 429M 305M 226M 142M
    Other Working Capital
    		 -626M -1.39B -5.98B 4.28B
    Other Non-Cash Items
    		 17M -19M 59M 54M
    Deferred Income Tax
    		 n/a 828M -559M -318M
    Change in Working Capital
    		 -78M -139M -3.46B 1.31B
    Operating Cash Flow
    		 -3B -3.12B 4.98B 13.62B
    Capital Expenditures
    		 -1.05B -707M -400M -284M
    Cash Acquisitions
    		 n/a -85M n/a n/a
    Purchase of Investments
    		 -6.53B -3.78B -11.44B -12.65B
    Sales Maturities Of Investments
    		 9.53B 8.78B 6.7B 4.44B
    Other Investing Acitivies
    		 n/a n/a -40M -30M
    Investing Cash Flow
    		 1.95B 4.21B -5.18B -8.52B
    Debt Repayment
    		 -10M -270M -184M -140M
    Common Stock Repurchased
    		 n/a -1.15B -3.33B -857M
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a n/a n/a n/a
    Financial Cash Flow
    		 56M -1.38B -3.45B -873M
    Net Cash Flow
    		 -999M -289M -3.64B 4.22B
    Free Cash Flow
    		 -4.05B -3.83B 4.58B 13.34B

    Add to Watchlist